|
disease
|
OMIM
disease |
gene OMIM
(analysis methods¹) |
localisation
|
|
Metabolic Disorders
|
|||
|
Contact: PD Dr. med. Ute Hehr, MD, Genetic counsellor ‑‑‑ Phone: +49‑941‑944‑5410 ‑‑‑
e-mail
|
|||
|
Familial intrahepatic cholestasis
|
|||
|
Benign recurrent intrahepatic cholestasis (BRIC1, BRIC2)
|
18q21
|
||
|
2q24
|
|||
|
Intrahepatic cholestasis of pregnancy)
|
7q21.1
|
||
|
18q21
|
|||
|
Progressive low γ-GT familial intrahepatic cholestasis (PFIC1, PFIC2, PFIC3)
|
18q21
|
||
|
2q24
|
|||
|
7q21.1
|
|||
|
thrombophilia (4 Mutations):
|
|||
|
Factor V-Leiden Mutation (1691G>A)
|
|
F5:
1691G>A
|
1q23
|
|
MTHFR 677C>T
|
|
MTHFR:
677C>T
|
1p36.3
|
|
MTHFR 1298A>C
|
|
MTHFR:
1298A>C
|
1p36.3
|
|
Prothrombin Mutation (20210G>A)
|
|
F2:
20210G>A
|
11p11-q12
|
|
Other
|
|||
|
Glucose-6-Phosphate Dehydrogenase Deficiency
|
Xq28
|
||
|
Cystic Fibrosis
|
CFTR
(36 Mutationen / S)
|
7q31.2
|
|
|
Surfactant metabolism dysfunction-3 (SMDP3)
|
16p13.3
|
||